Navigation Links
5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.

Products5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
Company SurModics, Inc.
Item 5X StabilCoat Immunoassay Stabilizer
Price Inquire
Description 5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product samples available upon request.
Info SurModics, Inc.SurModics, Inc.
9924 West 74th Street
Eden Prairie, MN 55344-3523
Customer Service: 866-SURMODX / 952-829-2700
Tech Support: 952-278-2638
Fax Number: 952-829-2743
Web Site: http://www.surmodics.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StabilCoat Plus Microsphere/Microarray Stabilizer from SurModics, Inc.
2. StabilCoat Plus Microsphere/Microarray Stabilizer from SurModics, Inc.
3. StabilCoat Immunoassay Stabilizer from SurModics, Inc.
4. 5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
5. Essential Data: Immunoassays from Promega
6. StabilGuard Choice Microsphere/Microarray Stabilizer from SurModics, Inc.
7. StabilZyme AP Conjugate Stabilizer from SurModics, Inc.
8. SuperFreeze Peroxidase Conjugate Stabilizer from Pierce Biotechnology, Inc.
9. StabilZyme HRP Conjugate Stabilizer from SurModics, Inc.
10. Coating Stabilizer from GenScript Corporation
11. Lyophilization Stabilizer from GenScript Corporation
... Immunogen: Synthetic peptide derived from the N-terminal ... ZO-1. Specificity: Specific for the N-terminus ... Reactivity: Human Dog Rat Mouse (positive controls: ... mouse liver heart blood vessel and brain ...
p-Raf-1 (Ser 338/Tyr 341)-R...
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
... Lauryl Ether 30% concentration ... Preservative. Surfactant. Clear Solution. ... is 1 mL of ... added to 400 mL ...
Biology Products:
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3New source of classical techniques for blood-based studies in the laboratory mouse 2Alcohol May Help Protect Trauma Patients 58685 1Anti Aging Drug Closer to Reality 58683 1Anti Aging Drug Closer to Reality 58683 2International LDN Awareness Week October 19 25th 2009 58681 1International LDN Awareness Week October 19 25th 2009 58681 2International LDN Awareness Week October 19 25th 2009 58681 3International LDN Awareness Week October 19 25th 2009 58681 4International LDN Awareness Week October 19 25th 2009 58681 5
... brain develops, neurons reach out helter-skelter forming new connections, ... the brain chooses which connections to keep and which ... branches have the most electrical activity—a finding that could ... , The work, published in the April 21 issue ...
... subpopulation of the antibody-producing B cells of the immune ... of immunity -- innate and acquired, Duke University Medical ... B-1a and B-1b cells they have uncovered offers basic ... vaccines, they said. , B cells are the arms ...
... damage caused by diabetes could bring relief to millions ... also reduce the number of amputations of toes and ... are borne out long-term. Nerve disease in diabetes is ... Europe and North America. , Scientists at The University ...
Other Biology News:Confirmation of human protein interaction data by human expression data 2Specialized immune-system B cells play double-barreled role 2Specialized immune-system B cells play double-barreled role 3Diabetic nerve therapy shows 'striking' results 2
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), ... royalty revenue from sales of Thalomid® during the ... $3.3 million. In addition, the Company anticipates ... for fiscal 2009. The difference in estimated ... be reflected in the fourth quarter financial results. ...
(Date:12/11/2009)... BOULDER, Colo., December 10, 2009 miRagen Therapeutics, ... lives by developing innovative microRNA-based therapeutics for cardiovascular ... data demonstrating that microRNA-206 (miR-206) plays a crucial ... (ALS or Lou Gehrig,s disease) and in neuromuscular ... in the December 11 issue of the journal ...
(Date:12/11/2009)... researchers have observed the "hot electron" effect in a ... the elusive charges using ultra-thin solar cells, opening a ... report in the current online edition of Applied ... solar cells, it generates free electrons in a range ... charges, the electrons must reach the bottom of the ...
(Date:12/11/2009)... 11 Algeta ASA (OSE: ALGETA), ... clinical center in the,US, the Tulane Cancer ... the phase III clinical study of Alpharadin ... prostate cancer,(CRPC) that has metastasized to the ... ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4